IFNAR1 depletion did not alter the tumorigenicity in vivo in colon adenocarcinoma, melanoma, pancreatic ductal adenocarcinoma or Lewis lung carcinoma models. This evidence concerns the gene IFNAR1 and pancreatic ductal adenocarcinoma.